These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 891377)
1. [Toxicology in cancer research. II. Cancerogenic drugs]. Schmähl D Dtsch Med Wochenschr; 1977 Jul; 102(29):1047-50. PubMed ID: 891377 [No Abstract] [Full Text] [Related]
2. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics. Newell DR; Burtles SS; Fox BW; Jodrell DI; Connors TA Br J Cancer; 1999 Nov; 81(5):760-8. PubMed ID: 10555743 [TBL] [Abstract][Full Text] [Related]
4. The Cancer Research UK experience of pre-clinical toxicology studies to support early clinical trials with novel cancer therapies. Newell DR; Silvester J; McDowell C; Burtles SS; Eur J Cancer; 2004 Apr; 40(6):899-906. PubMed ID: 15120045 [TBL] [Abstract][Full Text] [Related]
5. Toxicology of anticancer drugs. Guarino AM Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105 [No Abstract] [Full Text] [Related]
6. [Problems associated with molecular targeted drugs for cancer]. Kawaishi M; Koizum F; Nishio K Gan To Kagaku Ryoho; 2006 Oct; 33(10):1373-9. PubMed ID: 17033223 [TBL] [Abstract][Full Text] [Related]
7. [Toxicology in cancer research. I. Cancerogenic substances]. Schmähl D Dtsch Med Wochenschr; 1977 Jul; 102(28):1015-8. PubMed ID: 891368 [No Abstract] [Full Text] [Related]
8. Relation of preclinical toxicology to findings in early clinical trials. Grieshaber CK; Marsoni S Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115 [TBL] [Abstract][Full Text] [Related]
10. [Cancerogenic activity of antimitotic agents in animals]. Mazue G; Combes M Bull Cancer; 1983; 70(1):26-30. PubMed ID: 6839031 [TBL] [Abstract][Full Text] [Related]
11. Chemical carcinogenicity and the antineoplastic agents. Taylor AT; Wade AE Am J Hosp Pharm; 1984 Sep; 41(9):1844-8. PubMed ID: 6496522 [TBL] [Abstract][Full Text] [Related]
12. Innovations in cancer risk assessment (Ed study). Proceedings of a symposium sponsored by National Center for Toxicological Research, U.S. Food and Drug Administration, the American College of Toxicology. J Environ Pathol Toxicol; 1980; 3(3 Spec No):1-246. PubMed ID: 7365373 [No Abstract] [Full Text] [Related]
13. Hormesis gets massive data support. Renner R Environ Sci Technol; 2006 Nov; 40(21):6525-6. PubMed ID: 17144269 [No Abstract] [Full Text] [Related]
14. Multi-species toxicology approaches for oncology drugs: the US perspective. Tomaszewski JE Eur J Cancer; 2004 Apr; 40(6):907-13. PubMed ID: 15120046 [TBL] [Abstract][Full Text] [Related]
15. Chemical toxicity and chemical carcinogenesis. Is there a causal connection? A comparative morphological evaluation of 1500 experiments. Huff JE IARC Sci Publ; 1992; (116):437-75. PubMed ID: 1428093 [TBL] [Abstract][Full Text] [Related]
17. TNF is here to stay--revisited. ten Hagen TL; Eggermont AM; Lejeune FJ Trends Immunol; 2001 Mar; 22(3):127-9. PubMed ID: 11334026 [No Abstract] [Full Text] [Related]
18. The preclinical new drug research program of the National Cancer Institute. Driscoll JS Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438 [TBL] [Abstract][Full Text] [Related]
19. Cancer pharmacology in the elderly. Egorin MJ Semin Oncol; 1993 Feb; 20(1):43-9. PubMed ID: 8475409 [No Abstract] [Full Text] [Related]
20. Toxicology and pharmacology of the nitrosoureas. Oliverio VT Cancer Chemother Rep 3; 1973 May; 4(3):13-20. PubMed ID: 4201308 [No Abstract] [Full Text] [Related] [Next] [New Search]